DPP4 and colorectal cancer: TP53 could inhibit the ferroptosis process in human colorectal cancer cells by promoting the localization of DPP4 in the non-enzymatically active nucleus, and thus may promote the growth of human colorectal cancer cells (Xie et al., 2017).